BARRY RESSLER
Barry Ressler serves as Chief Executive Officer and Chairman of the Board of Directors of the International Space Medicine Consortium, an independent and collaborative scientific research & development-oriented Delaware corporation, seeking to enhance the knowledge of Space Medicine and related areas. Barry will provide direction for the company and oversee strategic planning, while leading the ISMC towards their short- and long-term goals.
Mr. Ressler brings a wealth of corporate leadership experience from his previous ventures that include Triton Thalassic Technologies Inc., EP Therapeutics, and especially STAR Associates Inc., a company engaged in consultation and strategic planning. He was previously Chairman of Universal Voltronics and managed programs, such as the Strategic Defense Initiative (Star Wars Program) for nearly 20 years. He brings board and governance experience from his tenure on the Boards of StemCyte, JMAR Technologies (a company focusing on extreme ultraviolet lithography for the defense and semiconductor industries, ASIC design/manufacturing and products for precision micro-machining); Nauticos Corp (Nauticos has developed advanced side scan sonar, ROV and research products used in the discovery of historic and contemporary sunken vessels including the Discovery Channel Titanic project and locating of the I-52 and DAKAR Submarines); EP Therapeutics and STAR Associates.
Mr. Ressler is a member of the UCONN Biotechnology Center External Advisory Board of the University of Connecticut, advising the University on the expansion of biotechnology research initiatives to foster University-Industry collaborative activities.
Barry is the holder of 7 patents in the field of monochromatic UV sterilization of industrial fluids,blood products, injectables, ophthalmic healthcare packaged products and parenteral drug delivery IV/renal bag technology,and food/beverage process applications. He has been an invited speaker at the Parenteral Drug Association and the FDA concerning aseptic and advanced sterilization technologies